Regulators are modernizing their expectations, and it's become clear that validation can no longer function as a point-in-time event.

The IQAir Atem Earth air purifier blows competitors out of the water with its elegant design and eco-friendly credentials.

Davis Real Estate Fund underperformed its benchmark in 2025 as passive inflows dominated the market, increasing the ...

In a company press release, Charles River said Glenn G. Coleman will become Corporate Executive Vice President and Chief Financial Officer on April 6, taking charge of the firm’s global finance ...

In today’s Pharmaceutical Executive Daily, the FDA begins reviewing Moderna’s seasonal flu vaccine under a revised regulatory approach, Eli Lilly signs a $100 million licensing agreement with CSL for ...

Every diet has its day in the sun, but emerging evidence is now casting a shadow on the hype of intermittent fasting.

The essays in a new anthology offer two distinct ways of interpreting the Promethean legacy of scientific progress.

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval of new drugs, the latest change from Trump administration ...

The Vermont author’s absorbing historical novel delves into the scientific discoveries and the tumultuous love life of the woman who discovered radium.

Panaji: Ryan Jovito Pinto, a convict in the Mandar Surlakar murder case undergoing a life sentence, approached the High Court seeking premature release. He stated that his conduct was exemplary, and ...

As a 41-year-old civil rights leader weighing a 1984 White House run, Jesse Jackson mixes prophetic zeal, sharp criticism and political ambition in this 1983 AP profile.

After public backlash, the FDA will review a new mRNA flu vaccine. That's good news, but its original rejection and other arbitrary decisions undermine U.S. leadership in biopharmaceutical innovation.